MAIER PAUL V

CIK 00011826158 companiesLA JOLLA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001182615

Recent Transactions

42 trades

Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2017-09-15+24,210→ 24,210 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2017-09-15+24,210→ 24,210 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Purchase Common Stock
2017-01-01$3.38/sh+4,100→ 4,100 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Purchase Common Stock
2017-01-01$3.38/sh+4,100→ 4,100 total
Award
SEELOS THERAPEUTICS, INC.
Stock Option (right to buy)
2016-01-04+25,000→ 25,000 total
Award
SEELOS THERAPEUTICS, INC.
Stock Option (right to buy)
2016-01-04+25,000→ 25,000 total
Award
SEELOS THERAPEUTICS, INC.
Stock Option (right to buy)
2014-02-06+9,000→ 9,000 total
Award
SEELOS THERAPEUTICS, INC.
Stock Option (right to buy)
2014-02-06+9,000→ 9,000 total
Award
SEELOS THERAPEUTICS, INC.
Stock Option (right to buy)
2014-01-02+16,000→ 16,000 total
Award
SEELOS THERAPEUTICS, INC.
Stock Option (right to buy)
2014-01-02+16,000→ 16,000 total
Award
SEQUENOM INC
Common Stock
2013-06-19+6,666→ 59,777 total
Award
International Stem Cell CORP$ISCO
Common Stock
2013-01-25+162,500→ 202,500 total
Award
Talon Therapeutics, Inc.
Stock Option (right to buy)
2013-01-25+47,000→ 47,000 total
Award
International Stem Cell CORP$ISCO
Common Stock
2013-01-25+162,500→ 202,500 total
Award
Talon Therapeutics, Inc.
Stock Option (right to buy)
2013-01-25+47,000→ 47,000 total
Exercise/Conversion
SEQUENOM INC
Common Stock
2011-06-01+6,250→ 43,750 total
Exercise/Conversion
SEQUENOM INC
Common Stock
2011-06-01+6,250→ 43,750 total
Exercise/Conversion
SEQUENOM INC
Restricted Stock Unit
2011-06-01−6,250→ 6,250 total
Exercise/Conversion
SEQUENOM INC
Restricted Stock Unit
2011-06-01−6,250→ 6,250 total
Award
PURE BIOSCIENCE, INC.$PURE
Common Stock
2011-01-21$2.13/sh+13,300→ 57,400 total
Exercise/Conversion
SEQUENOM INC
Common Stock
2010-01-20+6,250→ 6,250 total
Exercise/Conversion
SEQUENOM INC
Common Stock
2010-01-20+6,250→ 6,250 total
Exercise/Conversion
SEQUENOM INC
Restricted Stock Unit
2010-01-20−6,250→ 18,750 total
Exercise/Conversion
SEQUENOM INC
Restricted Stock Unit
2010-01-20−6,250→ 18,750 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2005-07-05+35,000→ 35,000 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2005-07-05+35,000→ 35,000 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Incentive Stock Option (right to buy)
2004-09-08−11,638→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2004-09-08$8.65/sh+11,638→ 64,703 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2004-09-08$9.10/sh+24,607→ 89,310 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Incentive Stock Option (right to buy)
2004-09-08−24,607→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2004-09-08$8.65/sh+11,638→ 64,703 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2004-09-08$9.10/sh+24,607→ 89,310 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Incentive Stock Option (right to buy)
2004-09-08−11,638→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Incentive Stock Option (right to buy)
2004-09-08−24,607→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2004-08-05$5.50/sh+5,700→ 53,065 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2004-08-05$5.50/sh+5,700→ 53,065 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2004-08-05−5,700→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2004-08-05−5,700→ 0 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2004-05-26$19.50/sh−2,000→ 56,929 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2004-05-26$19.50/sh−2,000→ 56,929 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Incentive Stock Option (right to buy)
2003-11-21−1,643→ 24,607 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2003-11-21$9.10/sh+1,643→ 56,453 total

Companies

Recent Filings

Address

C/O AMBRX BIOPHARMA INC. 10975 TORREY PINES ROAD

LA JOLLA, CA, 92037

View on SEC.gov